Palisade Bio, Inc.
PALI
$0.6902
-$0.0638-8.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -100.00% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -100.00% | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -100.00% | -100.00% |
| SG&A Expenses | -15.81% | -6.96% | -6.55% | -1.51% | -4.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.88% | -3.52% | 13.47% | 2.80% | 2.47% |
| Operating Income | 16.88% | 3.52% | -15.68% | -4.66% | -4.30% |
| Income Before Tax | 16.43% | 2.57% | -17.38% | -7.79% | -5.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.43% | 2.57% | -17.38% | -7.79% | -5.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.43% | 2.57% | -17.38% | -7.79% | -5.43% |
| EBIT | 16.88% | 3.52% | -15.68% | -4.66% | -4.30% |
| EBITDA | 16.88% | 3.52% | -15.69% | -4.69% | -4.32% |
| EPS Basic | 75.54% | 69.01% | 58.28% | 73.50% | 81.87% |
| Normalized Basic EPS | 75.04% | 68.50% | 57.69% | 72.99% | 80.71% |
| EPS Diluted | 75.54% | 69.01% | 58.28% | 73.53% | 81.89% |
| Normalized Diluted EPS | 75.04% | 68.50% | 57.69% | 72.99% | 80.71% |
| Average Basic Shares Outstanding | 327.01% | 320.49% | 210.37% | 210.46% | 244.62% |
| Average Diluted Shares Outstanding | 327.01% | 320.49% | 210.37% | 210.46% | 244.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |